Beaufort Capital exits getemed
Beaufort Capital has sold its 32% stake in medical technology company getemed to the firm’s management.
The transaction was financed via a senior loan from Deutsche Bank, a silent partnership with the Mittelständische Beteiligungsgesellschaft Berlin-Brandenburg and the buyers' own equity.
Michael Scherf and Robert Downes now jointly hold slightly more than 50%, while getemed founder Herwig Freiherr von Nettelhorst holds an estimated 30% stake in the firm.
Beaufort originally invested in getemed in 2007, when acquiring the shares in the firm from Berlin Capital Fund in a secondary buyout.
Company
getemed was founded in 1984 and is headquartered in Teltow, near Berlin. The firm researches, develops and manufacturers technology for medical monitors and cardiological functional diagnostics.
People
Stefan Friese is partner at Beaufort.
Advisers
Equity – Network Corporate Finance (Corporate finance).
Vendor – Warth & Klein Grant Thornton (M&A).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








